Therefore, we used NIS-A549 and two types of tumor cells that endogenously express NIS (thyroid carcinoma cell line K1 and gastric cancer MKN45) to assess the PET imaging capabilities of [18F]TFB in vivo and to expand its use in fundamental research and clinical treatment. This evidence concerns the gene SLC5A5 and gastric cancer.